Evidence map›Paper›PMID 30177761›Full record

ArticleNature structural & molecular biology2018

Influenza virus infection causes global RNAPII termination defects.

Nan Zhao, Vittorio Sebastiano, Natasha Moshkina, Nacho Mena, Judd Hultquist, David Jimenez-Morales, Yixuan Ma, Alex Rialdi, Randy Albrecht, Romain Fenouil and 23 more

Open access · bronzeAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 10 institutions in 5 countries.

Nan ZhaoDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Vittorio SebastianoDepartment of Obstetrics and Gynecology, Stanford University, Stanford, CA, USA.
Natasha MoshkinaDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nacho MenaDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0001-5464-7086
Judd HultquistDepartment of Medicine (Infectious Diseases), Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
David Jimenez-MoralesDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.
Yixuan MaDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Alex RialdiDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Randy AlbrechtDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0003-4008-503X
Romain FenouilIcahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Maria Teresa Sánchez-AparicioDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Juan AyllonDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Sweta RavisankarDepartment of Obstetrics and Gynecology, Stanford University, Stanford, CA, USA.
Bahareh HaddadDepartment of Obstetrics and Gynecology, Stanford University, Stanford, CA, USA.
Jessica Sook Yuin HoInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Diana LowInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Jian JinMount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0002-2387-3862
Vyacheslav YurchenkoLife Science Research Centre, Faculty of Science, University of Ostrava, Ostrava, Czech Republic.
Rab K PrinjhaEpinova Epigenetics Discovery Performance Unit, Immuno-Inflammation Therapy Area, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK.ORCID http://orcid.org/0000-0002-2666-3326
Alexander TarakhovskyLaboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, NY, USA.
Massimo SquatritoCancer Cell Biology Programme, Centro Nacional de Investigaciones Oncológicas, CNIO, Madrid, Spain.ORCID http://orcid.org/0000-0002-4593-3790
Dalila PintoDepartment of Psychiatry, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0002-8769-0846
Kimaada AlletteDepartment of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Minji ByunDepartment of Medicine, Clinical Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Melissa Laird SmithDepartment of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Robert SebraDepartment of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Ernesto GuccioneInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Terrence TumpeyInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Nevan KroganDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.
Benjamin GreenbaumTisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Harm van BakelIcahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0002-1376-6916
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Ivan MarazziDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. ivan.marazzi@mssm.edu.ORCID http://orcid.org/0000-0003-3376-0922
Icahn School of Medicine at Mount Sinai · USAgency for Science, Technology and Research · SGCalifornia Institute for Regenerative Medicine · USUniversity of California, San Francisco · USCenters for Disease Control and Prevention · USGlaxoSmithKline (United Kingdom) · GBNorthwestern University · USRockefeller University · USSpanish National Cancer Research Centre · ESUniversity of Ostrava · CZ

Funding

Virus CoreU19AI106754 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2013 to 2017
$26.0M
Mapping the role of long noncoding RNAs in gene regulatory networks in schizophreniaR01MH109715 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI PINTO, DALILA · 2018 to 2022
$4.0M
Multi-level analysis of influenza virus polymerase and its role in pathogenesisR01AI113186 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MARAZZI, IVAN, VAN BAKEL, HARM · 2015 to 2019
$3.0M
Transforming Genomics with 5 PB Big Omics Data Engine Cray CS300-AC SupercomputerS10OD018522 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2014 to 2014
$1.9M
NIAID NIH HHS HHSN272201400008CNIAID NIH HHS R01 AI113186NIAID NIH HHS U19 AI106754NIH HHS S10 OD018522NIMH NIH HHS R01 MH109715
6 · The paper itself

Abstract

Viral infection perturbs host cells and can be used to uncover regulatory mechanisms controlling cellular responses and susceptibility to infections. Using cell biological, biochemical, and genetic tools, we reveal that influenza A virus (IAV) infection induces global transcriptional defects at the 3' ends of active host genes and RNA polymerase II (RNAPII) run-through into extragenic regions. Deregulated RNAPII leads to expression of aberrant RNAs (3' extensions and host-gene fusions) that ultimately cause global transcriptional downregulation of physiological transcripts, an effect influencing antiviral response and virulence. This phenomenon occurs with multiple strains of IAV, is dependent on influenza NS1 protein, and can be modulated by SUMOylation of an intrinsically disordered region (IDR) of NS1 expressed by the 1918 pandemic IAV strain. Our data identify a strategy used by IAV to suppress host gene expression and indicate that polymorphisms in IDRs of viral proteins can affect the outcome of an infection.

Indexed as

HumansInfluenza A virusInfluenza, HumanRNA Polymerase IITerminator Regions, GeneticVirulenceRNA Polymerase II

Identifiers

PMID30177761
PMCPMC10754036
OpenAlexW2889076093

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.